Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > Strong Q2, Revenue YoY Growth, Profit Margin Expansion etc.
View:
Post by stockfy on Aug 03, 2021 8:35am

Strong Q2, Revenue YoY Growth, Profit Margin Expansion etc.

Excluding the one-time net revenue for contact and vaccine tracing services and product sales related to the COVID-19 pandemic in Q2 2020, core revenue YoY growth  was 13% compared with Q2 2020.

Gross profit margin in Q2 2021 increased YoY hitting 64% compared with 60% in Q2 2020. 

VMD recorded strong profitability for another quarter in a row.

VMD recorded strong positive operating cash flow for another quarter in a row.

VMD recorded strong positive free cash flow for another quarter in a row.

VMD maintained a pristine balance sheet with a strong net cash position that went UP sequentially, and therefore VMD can continue implementing its growth strategy.

And this growth strategy is both organic growth and inorganic growth through the acquisition of other smaller names.
Comment by JackLambert on Aug 03, 2021 8:46am
Good post.  it's worth dwelling on the surge in hiring and the perception that revenues are flattening.   The company is dealing with some difficult pandemic constraints.   But as has been said there are a lot of trained technicians and advocates ready to be deployed gainfully once the pandemic diminishes again.   seems to me they earn around 60,000. Glassdoor.   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities